» Articles » PMID: 18539026

Microwave-assisted Synthesis of 5-aminopyrazol-4-yl Ketones and the P38(MAPK) Inhibitor RO3201195 for Study in Werner Syndrome Cells

Overview
Specialty Biochemistry
Date 2008 Jun 10
PMID 18539026
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

5-Aminopyrazol-4-yl ketones are prepared rapidly and efficiently using microwave dielectric heating from beta-ketonitriles by treatment with N,N'-diphenylformamidine followed by heterocyclocondensation by irradiation with a hydrazine. The inhibitory activity of RO3201195 prepared by this methodology was confirmed in hTERT-immortalized HCA2 and WS dermal fibroblasts at 200nM concentration, both by ELISA and immunoblot assay, and displays excellent kinase selectivity for p38alpha MAPK over the related stress-activated kinase JNK.

Citing Articles

Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.

Rapetti F, Spallarossa A, Russo E, Caviglia D, Villa C, Tasso B Molecules. 2024; 29(10).

PMID: 38792163 PMC: 11124527. DOI: 10.3390/molecules29102298.


Amino-Pyrazoles in Medicinal Chemistry: A Review.

Lusardi M, Spallarossa A, Brullo C Int J Mol Sci. 2023; 24(9).

PMID: 37175540 PMC: 10177828. DOI: 10.3390/ijms24097834.


Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Bagley M, Davis T, Murziani P, Widdowson C, Kipling D Pharmaceuticals (Basel). 2016; 3(6):1842-1872.

PMID: 27713332 PMC: 4033955. DOI: 10.3390/ph3061842.


Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells.

Bagley M, Baashen M, Chuckowree I, Dwyer J, Kipling D, Davis T Pharmaceuticals (Basel). 2015; 8(2):257-76.

PMID: 26046488 PMC: 4491660. DOI: 10.3390/ph8020257.


Approaches towards the synthesis of 5-aminopyrazoles.

Aggarwal R, Kumar V, Kumar R, Singh S Beilstein J Org Chem. 2011; 7:179-97.

PMID: 21448263 PMC: 3063075. DOI: 10.3762/bjoc.7.25.